Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
WH Polonsky, RR Henry - Patient preference and adherence, 2016 - Taylor & Francis
At least 45% of patients with type 2 diabetes (T2D) fail to achieve adequate glycemic control
(HbA1c< 7%). One of the major contributing factors is poor medication adherence. Poor …
(HbA1c< 7%). One of the major contributing factors is poor medication adherence. Poor …
[HTML][HTML] An overview of the common methods used to measure treatment adherence
Methods This overview is based on an online search of PubMed database and includes the
relevant articles in this field. Results We included both direct and indirect methods for …
relevant articles in this field. Results We included both direct and indirect methods for …
Understanding the dimensions of anti-vaccination attitudes: The vaccination attitudes examination (VAX) scale
Background Anti-vaccination attitudes are important predictors of vaccination behavior.
Existing measures of vaccination attitudes focus on specific age groups and/or particular …
Existing measures of vaccination attitudes focus on specific age groups and/or particular …
Supporting adherence to medicines for long-term conditions
Pharmaceutical prescriptions are core to the treatment of most chronic illnesses, yet only half
are taken as prescribed. Despite the high costs of nonadherence to individuals and society …
are taken as prescribed. Despite the high costs of nonadherence to individuals and society …
Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care
B Clyne, JA Cooper, F Boland, CM Hughes… - British Journal of …, 2017 - bjgp.org
Background Polypharmacy (≥ 5 medications) is common in older patients and is associated
with adverse outcomes. Patients' beliefs about medication can influence their expectations …
with adverse outcomes. Patients' beliefs about medication can influence their expectations …
2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and …
Background Non-adherence to treatment could preclude reaching an optimal outcome.
Thirty to 80% of patients with rheumatic and musculoskeletal diseases (RMDs) do not …
Thirty to 80% of patients with rheumatic and musculoskeletal diseases (RMDs) do not …
Intentional and unintentional medication non-adherence in hypertension: the role of health literacy, empowerment and medication beliefs
L Náfrádi, E Galimberti, K Nakamoto… - Journal of public …, 2016 - journals.sagepub.com
Background Medication non-adherence is a major public health issue, creating obstacles to
effective treatment of hypertension. Examining the underlying factors of deliberate and non …
effective treatment of hypertension. Examining the underlying factors of deliberate and non …
Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers
Background Non-adherence to secondary prevention medicines (SPMs) among patients
with coronary artery disease (CAD) remains a challenge in clinical practice. This study …
with coronary artery disease (CAD) remains a challenge in clinical practice. This study …
Medication adherence and persistence in patients with autoimmune rheumatic diseases: a narrative review
Background Several drugs are available for the treatment of autoimmune rheumatic
diseases; however, their effectiveness may be negatively influenced by inappropriate …
diseases; however, their effectiveness may be negatively influenced by inappropriate …
Tailored interventions to improve medication adherence for cardiovascular diseases
HY Xu, YJ Yu, QH Zhang, HY Hu, M Li - Frontiers in pharmacology, 2020 - frontiersin.org
Over the past half-century, medical research on cardiovascular disease (CVD) has achieved
a great deal; however, medication adherence is unsatisfactory. Nearly 50% of patients do …
a great deal; however, medication adherence is unsatisfactory. Nearly 50% of patients do …